| 1 | The costs of traumatic brain injury: a literature review (10.2147/ceor.s44625) | Abstract References ORCID | 180.87 | 257 |
| 2 | Medical technology as a key driver of rising health expendit… (10.2147/ceor.s39634) | Abstract References ORCID | 163.42 | 150 |
| 3 | Review of the cost of venous thromboembolism (10.2147/ceor.s85635) | Abstract References ORCID | 162.99 | 148 |
| 4 | Health care costs associated with venous thromboembolism in… (10.2147/ceor.s39964) | Abstract References ORCID | 157.01 | 123 |
| 5 | Respiratory syncytial virus: current and emerging treatment… (10.2147/ceor.s60710) | Abstract References ORCID | 154.83 | 115 |
| 6 | The clinical and economic burden of chronic obstructive pulm… (10.2147/ceor.s34321) | Abstract References ORCID | 153.69 | 111 |
| 7 | Adherence to disease-modifying therapies and its impact on r… (10.2147/ceor.s130334) | Abstract References ORCID | 153.10 | 109 |
| 8 | Transferability of health technology assessments and economi… (10.2147/ceor.s14404) | Abstract References ORCID | 148.67 | 95 |
| 9 | Home hemodialysis: a comprehensive review of patient-centere… (10.2147/ceor.s69340) | Abstract References ORCID | 147.28 | 91 |
| 10 | Impact of dry eye on work productivity (10.2147/ceor.s36352) | Abstract References ORCID | 146.57 | 89 |
| 11 | Opioid-induced constipation in patients with chronic noncanc… (10.2147/ceor.s61602) | Abstract References ORCID | 145.46 | 86 |
| 12 | The direct health-care burden of valvular heart disease: evi… (10.2147/ceor.s112691) | Abstract References ORCID | 144.71 | 84 |
| 13 | Adherence to antihypertensive medications and health outcome… (10.2147/ceor.s15619) | Abstract References ORCID | 143.93 | 82 |
| 14 | Impact of scribes on patient interaction, productivity, and… (10.2147/ceor.s49010) | Abstract References ORCID | 140.63 | 74 |
| 15 | Short- and longer-term health-care resource utilization and… (10.2147/ceor.s95662) | Abstract References ORCID | 140.63 | 74 |
| 16 | Estimating the willingness to pay for a quality-adjusted lif… (10.2147/ceor.s38062) | Abstract References ORCID | 140.19 | 73 |
| 17 | Biosimilar medicines and cost-effectiveness (10.2147/ceor.s12494) | Abstract References ORCID | 139.75 | 72 |
| 18 | Patient-level costs of major cardiovascular conditions: a re… (10.2147/ceor.s89331) | Abstract References ORCID | 136.47 | 65 |
| 19 | Challenges in measuring and valuing productivity costs, and… (10.2147/ceor.s44866) | Abstract References ORCID | 135.97 | 64 |
| 20 | Techniques for estimating health care costs with censored da… (10.2147/ceor.s31552) | Abstract References ORCID | 134.95 | 62 |
| 21 | Health-resource use and costs associated with fibromyalgia i… (10.2147/ceor.s41111) | Abstract References ORCID | 132.81 | 58 |
| 22 | <p>Electronic referral systems in health care: a scopi… (10.2147/ceor.s195597) | Abstract References ORCID | 131.69 | 56 |
| 23 | Drug tendering: drug supply and shortage implications for th… (10.2147/ceor.s140063) | Abstract References ORCID | 130.53 | 54 |
| 24 | Impact of early intervention and disease modification in pat… (10.2147/ceor.s22265) | Abstract References ORCID | 128.07 | 50 |
| 25 | A systematic review of observational studies evaluating cost… (10.2147/ceor.s115689) | Abstract References ORCID | 126.76 | 48 |
| 26 | The cost of dysphagia in geriatric patients (10.2147/ceor.s165713) | Abstract References ORCID | 126.76 | 48 |
| 27 | Cost analysis of magnetically controlled growing rods compar… (10.2147/ceor.s113633) | Abstract References ORCID | 126.09 | 47 |
| 28 | The financial burden of sickle cell disease on households in… (10.2147/ceor.s86599) | Abstract References ORCID | 125.41 | 46 |
| 29 | Sugammadex for reversal of neuromuscular blockade: a retrosp… (10.2147/ceor.s100921) | Abstract References ORCID | 124.71 | 45 |
| 30 | Health and economic benefits of physical activity for patien… (10.2147/ceor.s115103) | Abstract References ORCID | 124.71 | 45 |
| 31 | A&nbsp;systematic review of the effectiveness of taxes o… (10.2147/ceor.s49659) | Abstract References ORCID | 124.71 | 45 |
| 32 | Cost of noninfectious comorbidities in patients with HIV (10.2147/ceor.s40607) | Abstract References ORCID | 123.26 | 43 |
| 33 | Time and resources of peripherally inserted central catheter… (10.2147/ceor.s121230) | Abstract References ORCID | 120.96 | 40 |
| 34 | Epidemiology of falls and osteoporotic fractures: a systemat… (10.2147/ceor.s38721) | Abstract References ORCID | 120.96 | 40 |
| 35 | Estimating the health care burden of prescription opioid abu… (10.2147/ceor.s85213) | Abstract References ORCID | 120.96 | 40 |
| 36 | Evaluating health-related quality of life in type 1 diabetes… (10.2147/ceor.s114699) | Abstract References ORCID | 120.15 | 39 |
| 37 | Fluid overload is associated with increases in length of sta… (10.2147/ceor.s45873) | Abstract References ORCID | 120.15 | 39 |
| 38 | Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in me… (10.2147/ceor.s82194) | Abstract References ORCID | 120.15 | 39 |
| 39 | Annual impact of scribes on physician productivity and reven… (10.2147/ceor.s89329) | Abstract References ORCID | 120.15 | 39 |
| 40 | Cost&ndash;utility analysis of prophylaxis versus treatm… (10.2147/ceor.s16670) | Abstract References ORCID | 119.33 | 38 |
| 41 | Pain severity and the economic burden of neuropathic pain in… (10.2147/ceor.s63323) | Abstract References ORCID | 119.33 | 38 |
| 42 | Early enteral nutrition in critical illness: a full economic… (10.2147/ceor.s50722) | Abstract References ORCID | 118.48 | 37 |
| 43 | The use of sugammadex for bariatric surgery: analysis of rec… (10.2147/ceor.s109951) | Abstract References ORCID | 117.62 | 36 |
| 44 | Estimated hospital costs associated with preventable health… (10.2147/ceor.s102505) | Abstract References ORCID | 115.81 | 34 |
| 45 | Update on the management of cirrhosis &ndash; focus on c… (10.2147/ceor.s30675) | Abstract References ORCID | 115.81 | 34 |
| 46 | Glycemic control and diabetes-related health care costs in t… (10.2147/ceor.s41846) | Abstract References ORCID | 115.81 | 34 |
| 47 | Cost-effectiveness analysis of online hemodiafiltration vers… (10.2147/ceor.s109649) | Abstract References ORCID | 113.89 | 32 |
| 48 | Leuprolide acetate 1-, 3- and 6-monthly depot formulations i… (10.2147/ceor.s44855) | Abstract References ORCID | 113.89 | 32 |
| 49 | Early parenteral nutrition in critically ill patients with s… (10.2147/ceor.s48821) | Abstract References ORCID | 113.89 | 32 |
| 50 | Screening strategies for active tuberculosis: focus on cost-… (10.2147/ceor.s92244) | Abstract References ORCID | 113.89 | 32 |